Published in J Biol Stand on January 01, 1984
Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus. PLoS Comput Biol (2010) 0.98
Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus. J Gen Virol (2014) 0.91
Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses. Vaccine (2014) 0.91
Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East. Vaccine (2013) 0.88
Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains. Vaccine (2014) 0.81
Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis. J Gen Virol (2015) 0.79
Molecular characterization of foot-and-mouth disease virus type C of Indian origin. J Clin Microbiol (2005) 0.75
Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. J Hyg (Lond) (1978) 1.47
Malignant catarrhal fever virus in nasal secretions of wildebeest: a probable mechanism for virus transmission. J Wildl Dis (1974) 1.11
Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch Virol (1979) 1.07
Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine (1987) 1.06
The relationship between serum antibody titres and protection from foot and mouth disease in pigs after oil emulsion vaccination. J Biol Stand (1984) 0.96
Neutralization kinetics studies with type SAT2 foot-and-mouth disease virus strains. 1. Factors that influence the rate and pattern of neutralization. J Hyg (Lond) (1977) 0.96
Serological findings in bovine herpes mammillitis. Br Vet J (1969) 0.95
Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction. J Biol Stand (1984) 0.95
Observations on foot-and-mouth disease type SAT 2 in Tanzania. August 1968 to August 1969. Bull Epizoot Dis Afr (1970) 0.95
Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus. J Gen Virol (1984) 0.94
The control of rinderpest in Tanzania between 1997 and 1998. Trop Anim Health Prod (2002) 0.92
Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses. Dev Biol Stand (1976) 0.92
The effect of maternally derived antibodies on the response of calves to vaccination against foot and mouth disease. J Hyg (Lond) (1984) 0.91
Neutralization kinetics studies with type SAT 2 foot-and-mouth disease virus strains. J Hyg (Lond) (1977) 0.89
Veterinary vaccines and their use in developing countries. Rev Sci Tech (2007) 0.89
Dose-response relationships in a microneutralization test for foot-and-mouth disease viruses. J Hyg (Lond) (1978) 0.88
The use of a logistic model for the quantitative interpretation of indirect sandwich enzyme labelled immunosorbent assays (ELISA) for antibodies and antigens in foot and mouth disease. Comput Biol Med (1985) 0.87
Observations on the behaviour of rinderpest virus in immune animals challenged intransally. Bull Epizoot Dis Afr (1974) 0.86
Foot-and-mouth disease vaccination: a multifactorial study of the influence of antigen dose and potentially competitive immunogens on the response of cattle of different ages. Res Vet Sci (1986) 0.83
The association of calf serum with the contamination of BHK21 clone 13 suspension cells by a parvovirus serologically related to the minute virus of mice (MVM). Arch Virol (1980) 0.81
Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge. Vaccine (1992) 0.80
Effect of age on response of cattle to vaccination against foot-and-mouth disease. Br Vet J (1985) 0.80
Sources of variability in foot and mouth disease vaccine potency estimates based on serum neutralizing antibody assay. J Biol Stand (1987) 0.80
Guanidine and heat sensitivity of foot-and-mouth disease virus (FMDV) strains. J Hyg (Lond) (1982) 0.80
Bovine herpes mammillitis virus. 3. Observations on experimental infection. Br Vet J (1968) 0.79
The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle. Dev Biol Stand (1986) 0.78
Probable occurrence of infectious bovine rhinotracheitis virus in Tanzania in wildlife and cattle. Nature (1970) 0.78
Some observations on herpes virus mammillitis of bovine animals. Vet Rec (1966) 0.78
Bovine herpes mammillitus virus. I. In-vitro behaviour of the virus. Br Vet J (1967) 0.78
Studies on the stability of foot-and-mouth disease virus using absorbance - temperature profiles. Dev Biol Stand (1983) 0.78
A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle. Vaccine (1992) 0.77
The effect of antiserum quality on strain specificity assessment of foot and mouth disease virus by the neutralization reaction. J Biol Stand (1984) 0.77
The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle. J Biol Stand (1984) 0.77
Serological analysis of recent type O foot-and-mouth disease virus isolates from Europe. Vet Rec (1982) 0.76
Evaluation of the antigenic variation within type-A foot and mouth disease virus isolates from Asia. J Biol Stand (1984) 0.76
A serological evaluation of 1979-1982 Kenyan foot-and-mouth disease type SAT 2 viruses. J Hyg (Lond) (1983) 0.76
The differentiation of foot and mouth disease virus strains using an indirect sandwich enzyme-linked immunosorbent assay saturation model. J Biol Stand (1984) 0.75
The changing face of foot-and-mouth disease (FMD) control. Br Vet J (1992) 0.75
An indirect haemagglutination test for the detection of antibody to Nairobi sheep disease virus. Res Vet Sci (1976) 0.75
Efficacy of avridine as an adjuvant for Newcastle disease virus antigen in chickens. Am J Vet Res (1986) 0.75
Studies on cell cultures persistently infected with bovine herpes mammillitis virus. The possible role of deionised water in inducing a carrier status. Br Vet J (1972) 0.75
Isolation of infectious bovine rhinotracheitis virus in Tanzania. Trop Anim Health Prod (1971) 0.75
Variations in the buoyant density of foot-and-mouth disease virus strains. Arch Virol (1982) 0.75
Studies on viral interference induced by rinderpest virus: interference and interferon induction by tissue culture rinderpest vaccine (TCRV) virus in vitro. Zentralbl Veterinarmed B (1980) 0.75
A serological comparison of seven strains of bovine herpes mammillitis virus. Res Vet Sci (1969) 0.75
Observations on the development of serum neutralizing antibody in rinderpest infection. Bull Epizoot Dis Afr (1974) 0.75
The incidence of infectious bovine rhinotracheitis antibody in Tanzanian game animals and cattle. Bull Epizoot Dis Afr (1974) 0.75
Graphical method for comparative statistical study of vaccine potency tests. Vaccine (1984) 0.75
Isolation of "non-syncytia forming" herpes viruses from cattle in Tanzania. J Comp Pathol (1973) 0.75
An indirect sandwich enzyme labelled immunosorbent assay for the detection of foot and mouth disease virus immunizing antigen in tissue culture harvests. J Biol Stand (1984) 0.75
Computerization of foot and mouth disease virus strain relationship data. Vaccine (1983) 0.75
Bovine herpes mammillitis virus. II. Standardization of an in-vitro serum neutralization test. Br Vet J (1968) 0.75
Persistent infection of cattle with the herpesvirus of malignant catarrhal fever and observations on the pathogenesis of the disease. Br Vet J (1976) 0.75
Studies on viral interference induced by rinderpest virus: inactivation of tissue culture rinderpest vaccine virus by heat treatment at 56 degrees C and by ultraviolet irradiation. Zentralbl Veterinarmed B (1980) 0.75
Observations on the histopathology of bovine herpes mammillitis. Res Vet Sci (1969) 0.75
Evaluation of the xerovac process for the preparation of heat tolerant contagious bovine pleuropneumonia (CBPP) vaccine. Vaccine (2005) 0.75
Regulatory framework and requirements for managing risks associated with veterinary biological products in Africa: present systems and future needs. Rev Sci Tech (1995) 0.75
Studies on viral interference induced by rinderpest virus: 3. Interferon induction by attenuated and virulent strains of rinderpest virus in tissue culture. Bull Anim Health Prod Afr (1982) 0.75
[Vaccination strategies for contagious bovine pleuropneumonia in Africa]. Rev Sci Tech (1995) 0.75
Some applications of a graphical method for the comparative statistical study of vaccine potency assays. Vaccine (1984) 0.75
Studies on viral interference induced by rinderpest virus: 4. Induction of circulating interferon and antibodies in buffaloes following inoculation with tissue culture rinderpest vaccine (TCRV) virus. Bull Anim Health Prod Afr (1982) 0.75
General principles governing the diagnosis of virus diseases of animals. Bull Epizoot Dis Afr (1972) 0.75
Immune response in cattle induced by inactivated rabies vaccine adjuvanted with aluminium hydroxide either alone or in combination with avridine. Rev Sci Tech (1993) 0.75
Disease prevention and preparedness: the Food and Agriculture Organization Emergency Prevention System. Rev Sci Tech (1999) 0.75
Electron microscopical studies on "non-syncytia forming" bovine herpes viruses isolated in Tanzania. J Comp Pathol (1974) 0.75
The development of a vaccine for bovine herpes mammillitis. Res Vet Sci (1969) 0.75
Observations on the first epidemic of foot-and-mouth disease type SAT 1 in Tanzania. Bull Epizoot Dis Afr (1973) 0.75
The application of a single radial haemolysis technique to foot-and-mouth disease virus-antibody study. Arch Virol (1980) 0.75